Afrezza® is the only ultra rapid-acting inhaled insulin that starts lowering blood sugars in ~12 minutes for adults living with type 1 or type 2 diabetes.
Afrezza®, the only ultra rapid-acting inhaled insulin, delivers glucose management in the
moment for adults living with type 1 or type 2 diabetes.
Learn more about Afrezza®, the only ultra rapid-acting inhaled insulin.
Afrezza® lets you inhale your insulin right when food arrives — even unexpectedly — so you can be spontaneous but still in control.
Afrezza® lowers your blood sugar fast*, similar to the body’s natural insulin response.
*Starts lowering blood sugars in ~12 minutes.
Afrezza® lowers your blood sugar at mealtime without the need for mealtime injections.
Afrezza® has proven mealtime control in studies of more than 3,000 people with either type 1 or type 2 diabetes.
UpScript*, a telemedicine platform, lets you speak with a healthcare provider to see if Afrezza® is right for you, all from the comfort of your own home.
Find a healthcare provider near you that has experience prescribing Afrezza®.**
Learn what to expect when taking Afrezza®, how to store it, and more.
Whether you are new to Afrezza® or just want to learn more, our Patient Support Guides are here to provide personalized support through every step of the Afrezza® journey.
Tell us a little about yourself and we’ll send you information and resources.
* Third-party website; does not constitute an endorsement or recommendation by MannKind Corporation.
** The physician locator tool is provided by MannKind Corp. (“MannKind”) solely to assist you in locating a physician who has experience with Afrezza®. This physician locator tool should not be construed in any way as an endorsement or recommendation by MannKind as to the qualifications of any physicians listed in this tool or the quality of medical care they can provide. MannKind makes no guarantees that using a physician from this list will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. MannKind recommends that you meet and discuss the benefits and risks of treatments and the procedure to administer the product with the potential physician.
*** What you pay for Afrezza® will depend on your insurance plan. Each plan has different preferred drug lists and out-of-pocket amounts, and most include an annual deductible. If you haven’t met your deductible, you’ll see higher prices until the deductible is met, then your out-of-pocket cost will likely drop. This offer is available for patients with commercial drug insurance coverage. It is not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Maximum savings limit applies; patient out-of-pocket expense may vary. If the patient’s health plan does not cover Afrezza® or requires a prior authorization, contact AfrezzaAssist℠ for more information. If approved by the patient’s health plan to take Afrezza®, a patient will pay as little as $35 per month. This applies to patient out-of-pocket costs, including deductible, co-insurance, and copayments for Afrezza®. See full Program Terms, Conditions, and Eligibility Criteria.
References:
US-AFR-2399
AFREZZA is a man-made insulin that is breathed-in through your lungs (inhaled) and is used to control high blood sugar in adults with diabetes mellitus.
What is the most important information I should know about AFREZZA? AFREZZA can cause serious side effects, including:
Sudden lung problems (bronchospasms). In a study, some AFREZZA-treated patients with asthma, whose asthma medication was temporarily withheld, experienced sudden lung problems. Do not use AFREZZA if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting AFREZZA, your healthcare provider will give you a breathing test to check how your lungs are working.
Do not use Afrezza® if you:
Before using Afrezza®, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins or herbal supplements.
Before you start using Afrezza®, talk to your healthcare provider about low blood sugar and how to manage it.
While using Afrezza® do not:
Afrezza® may cause serious side effects that can lead to death, including:
See “What is the most important information I should know about Afrezza®?”
Treatment with TZDs and Afrezza® may need to be changed or stopped by your healthcare provider if you have new or worse heart failure.
Get emergency medical help if you have:
• Trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, confusion.
The most common side effects of Afrezza® include:
These are not all the possible side effects of Afrezza®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).
Please See Full Prescribing Information, including BOXED WARNING, Medication Guide and Instructions for Use for AFREZZA.
AFREZZA, the Afrezza logo, AFREZZAASSIST, AFREZZAASSIST and logo, MANNKIND, and BLUHALE VIS are registered trademarks of MannKind Corporation. © 2024 MannKind Corporation.
This site is intended for use by U.S. residents only.
Complete a quick medical questionnaire to help determine if Afrezza is right for you.
Schedule an appointment with a licensed healthcare provider.
If Afrezza is right for you, pick it up from your local pharmacy or have it delivered to your home.
You are now leaving Afrezza.com
By clicking “Yes” below, you acknowledge and agree that MannKind does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. MannKind makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. MannKind recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. MANNKIND AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “YES” to proceed to the third-party website. If you do not agree to the above, click “NO” to remain on Afrezza.com.